Citations: | - Pei H, Li L, Fridley BL, Jenkins GD et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 2009 Sep 8;16(3):259-66. PMID: 19732725
- Li L, Zhang JW, Jenkins G, Xie F et al. Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer. Pharmacogenet Genomics 2016 Dec;26(12):527-537. PMID: 27749787
- Ellsworth KA, Eckloff BW, Li L, Moon I et al. Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma. PLoS One 2013;8(8):e70216. PMID: 23936393
|
---|